Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Revenue

Optipharm.CO.,LTD had revenue of 6.59B KRW in the quarter ending June 30, 2026, with 13.80% growth. This brings the company's total for the last twelve months to 23.59B, up 11.84% year-over-year. In the year 2025, Optipharm.CO.,LTD had annual revenue of 22.34B with 13.79% growth. That makes Optipharm.CO.,LTD the 34,535th largest company in the world by revenue and 2,212th in South Korea.

• Revenue (ttm): 23.59B
• Revenue Growth: +11.84%
• P/S Ratio: 2.78
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 65.57B

Revenue Chart

Chart

Chart

Revenue by Segment

• Animal Medicine 10.11B 51.5%
• Animal Disease Diagnosis 5.53B 28.2%
• Bacteriophage 2.04B 10.4%
• Medipig 1.68B 8.6%
• Other 269.14M 1.4%

Fiscal year ended Dec 31, 2024 See the full Optipharm.CO.,LTD breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	22.34B	2.71B	13.79%
Dec 31, 2024	19.64B	2.26B	13.03%
Dec 31, 2023	17.37B	1.36B	8.52%
Dec 31, 2022	16.01B	1.75B	12.27%
Dec 31, 2021	14.26B	1.21B	9.29%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error